Globus Medical (GMED) Tops Q3 EPS by 5c

Globus Medical (NYSE: GMED) reported Q3 EPS of $0.50, $0.05 better than the analyst estimate of $0.45. Revenue for the quarter came in at $229.7 million versus the consensus estimate of $228.31 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Globus Medical wins CE mark for Excelsius3D imaging system in EU
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy